Skip to main content
Top
Published in: Breast Cancer Research 1/2002

01-07-2002 | Meeting abstract

An audit of benign biopsies performed in patients assessed by the Leeds/Wakefield Breast Screening Unit

Authors: PJ Carder, JC Liston

Published in: Breast Cancer Research | Special Issue 1/2002

Login to get access

Excerpt

This audit was performed in order to clarify any relationship between an increase in benign biopsies and use of the B3 core biopsy category. Women who had been screened between 1 April 1999 and 31 March 2000 by Leeds/Wakefield Breast Screening Service and who had undergone a surgical biopsy for a lesion subsequently proving benign were identified and all pre-operative investigations reviewed. Thirty-six women had undergone a surgical excision biopsy for a benign lesion and 22 of these (61%) had had a B3 biopsy categorisation. Twelve of these reflected a pathological suggestion of radial scar but there were 10 others and a wide variety of lesions were represented. Two papillary lesions, two fibro-epithelial lesions, two difficult intraductal epithelial proliferations and two biopsies containing pools of stromal mucin were found, as was one case of atypical lobular hyperplasia and one unusual vascular lesion. …
Metadata
Title
An audit of benign biopsies performed in patients assessed by the Leeds/Wakefield Breast Screening Unit
Authors
PJ Carder
JC Liston
Publication date
01-07-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr528

Other articles of this Special Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine